Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL18787201

COCC(N)C(=O)NC(C)C(=O)NCc1cccc2ccccc12.O=C(O)C(F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
PSMB8 P28062 8/20 0.48
PSMB5 P28074 7/20 0.48
OPRD1 P41143 1/20 0.47
ANPEP P15144 1/20 0.44
F2 P00734 1/20 0.44
CASP3 P42574 2/20 0.42
CASP6 P55212 2/20 0.42
CASP8 Q14790 2/20 0.42
CARM1 Q86X55 1/20 0.41
PRMT6 Q96LA8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL18787200 1.00 KDM4E (0.51) KDM4EALDH1A1TDP1PSMB8PSMB5
SCHEMBL16908241 0.93 KDM4E (0.55) KDM4EALDH1A1TDP1PSMB8PSMB5
Trifluoroacetic Acid SCHEMBL18787173 0.92 KDM4E (0.54) KDM4EALDH1A1TDP1PSMB8PSMB5
Trifluoroacetic Acid SCHEMBL18787174 0.92 KDM4E (0.54) KDM4EALDH1A1TDP1PSMB8PSMB5
Trifluoroacetic Acid SCHEMBL16899307 0.88 PSMB8 (0.49) PSMB8PSMB5OPRD1ANPEPF2
Trifluoroacetic Acid SCHEMBL16899247 0.88 PSMB8 (0.49) PSMB8PSMB5OPRD1ANPEPF2
Trifluoroacetic Acid SCHEMBL16899193 0.85 PSMB8 (0.53) KDM4EALDH1A1TDP1PSMB8PSMB5
Trifluoroacetic Acid SCHEMBL16899197 0.85 PSMB8 (0.53) KDM4EALDH1A1TDP1PSMB8PSMB5
SCHEMBL16899279 0.84 KDM4E (0.58) KDM4EALDH1A1TDP1PSMB8PSMB5
SCHEMBL16899126 0.84 KDM4E (0.58) KDM4EALDH1A1TDP1PSMB8PSMB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE49816-E1 Dipeptides as inhibitors of human immunoproteasomes CORNELL UNIVERSITY (US) 2024-01-30 US disclosed
EP-3092244-B1 DIPEPTIDES AS INHIBITORS OF HUMAN IMMUNOPROTEASOMES UNIV CORNELL (US) 2019-08-14 EP disclosed
US-9988421-B2 Dipeptides as inhibitors of human immunoproteasomes CORNELL UNIVERSITY (US) 2018-06-05 US disclosed
US-20170121366-A1 DIPEPTIDES AS INHIBITORS OF HUMAN IMMUNOPROTEASOMES CORNELL UNIVERSITY 2017-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170121366-A1 DIPEPTIDES AS INHIBITORS OF HUMAN IMMUNOPROTEASOMES DNPEP, PSMB10, DPEP1 KDM4E 809/4885ALDH1A1 3918/4885TDP1 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.